Yaz Lawsuit Plaintiffs Receive Settlements
Plaintiffs in a Yasmin or Yaz lawsuit are currently receiving settlements. Anyone who has suffered a blood clot injury and who used the Bayer combination oral contraceptive should contact an experienced law firm today. Our legal team has already been involved in settling several groups of Yaz injury cases for their clients. Please complete our free case review form to begin your Yaz Lawsuit.
Bayer in April 2013 lost its Yaz patent, but, as Yaz lawsuits and settlements bear out, the corporation did not forfeit its potential liability for illnesses that can be traced to the use of Yaz.
Yaz Lawsuit Injuries
The injuries claimed in Yaz lawsuits include venous thromboembolism, or VTE. Based on scientific information available at the time, the FDA in April 2012 updated the warnings and precautions for Yaz/Yasmin to include the increased risks of “thromboembolic disorders and other vascular problems.”
Yaz Side Effects Contribute to Blood Clot Injuries
Indeed, the combination oral contraceptive’s label reads that the drug “may be associated with a higher risk” of VTE “than COCs containing the progestin levonorgestrel or some other progestins” because Yaz is a drospirenone-containing combination oral contraceptive with 0.03 mg ethinyl estradiol. The risk of VTE in contraceptives in Yaz’s class is scientifically proven to be as high as three-fold the VTE risk associated with the other type of oral contraceptive, according to Yaz’s prescribing information. The increased risk is a key assertion in Yaz lawsuits.
Venous thromboembolism injuries that plaintiffs in Yaz lawsuits have suffered include a deep vein thrombosis and a pulmonary embolism. As the FDA writes, “A deep vein thrombosis is a rare but serious condition where a blood clot forms inside a vein. These blood clots usually form in the lower leg or thigh, but can break loose and travel to other areas of the body such as the lungs. If the clot travels to the lung, it is called a pulmonary embolism, a potentially fatal condition where an artery in the lung becomes blocked.”
Pulmonary embolism is so dangerous that, according to Johns Hopkins Hospital, “Patients with a PE have a 30 percent to 60 percent chance of dying from it.”
Yaz lawsuits have reported horror stories
There is nothing innocuous about Yaz injuries. In a Yaz lawsuit out of Florida, plaintiff’s petition pointed out, “In fact, in less than a five-year period, from the first quarter of 2004 through the third quarter of 2008, over 50 reports of death [and serious injury] have been filed with the FDA.” These reports include deaths and serious injury associated with deep vein thrombosis, or DVT, pulmonary embolism and stroke. “Some deaths reported occurred in women as young as 17 years old.”
Hence, according to the reasoning behind the Yaz lawsuit, “Prior to Plaintiff’s use of Yasmin Defendants knew or should have known that use [of] Yasmin created a higher risk of serious personal injury than other oral contraceptives on the market, including but not limited to second generation oral contraceptives, and that, when taken as directed, such use was unreasonably dangerous to consumers. Therefore, at the time Plaintiff used Yasmin, Defendants knew or should have known that the use of Yasmin created an increased risk to consumers of serious personal injury,” including deep vein thrombosis, pulmonary embolism, stroke and even death.
Nearly 10,000 Yaz lawsuits have been centralized before the U.S. District Court for the Southern District of Illinois.
Current State of Yaz Lawsuit
Bayer briefed its investors on the status of Yaz lawsuits as follows in its annual report for 2012, which was released in February 2013: “As of February 12, 2013, the number of [Yaz] lawsuits pending in the United States and served upon Bayer was about 10,000. In addition, about 1,200 asserted claims were pending that have not been filed in court. The number of claimants in the pending lawsuits and claims totaled about 13,600 (excluding claims already settled).
“Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin and/or Yaz or from the use of Ocella and/or Gianvi, generic versions of Yasmin and Yaz, respectively, marketed by Barr Laboratories Inc. in the United States. Claimants seek compensatory and punitive damages, claiming, in particular, that Bayer knew, or should have known, of the alleged risks and should be held liable for having failed to disclose them or adequately warn users. All cases pending in U.S. federal courts have been consolidated in a multidistrict litigation (MDL) proceeding for common pre-trial management. In Canada, 13 class actions have been served upon Bayer as of February 12, 2013.”
Bayer, a German corporation, in 2012 put a dollar figure on settlements and other costs related to Yaz lawsuits. Referring to certain costs for its third-quarter of 2012 financial report, Bayer Board Chairman Dr. Marijn Dekkers reported Oct. 30, 2012, “The largest item here was EUR 205 million in further accounting measures we took in connection with the oral contraceptives Yasmin and Yaz — without admission of liability — for all currently known cases involving venous clot injuries that Bayer considers to be worthy of settlement.”
File a Yaz Lawsuit Today if You’ve Been Affected
There is no need for a Yaz/Yasmin user diagnosed with VTE or another serious injury to suffer silently when the victim can have an attorney investigate whether there is a case for a viable Yaz lawsuit that can hold the manufacturer accountable. Contact us today and get an experienced pharmaceutical injury attorney to handle your Yaz lawsuit and to pursue the compensation that may be in order. The law firm, which operates in every state, may be reached by completing our free case review form.
Filed under: Yaz Lawsuit
Like this post? Subscribe to my RSS feed and get loads more!